Growth Metrics

Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)

Legend Biotech filings provide 6 years of Other Non Operating Income readings, the most recent being -$2.4 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 102.15% to -$2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$164.7 million, a 1354.91% decrease, with the full-year FY2025 number at -$164.8 million, down 247.41% from a year prior.
  • Other Non Operating Income hit -$2.4 million in Q4 2025 for Legend Biotech, down from $354000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $111.4 million in Q4 2024 to a low of -$108.1 million in Q2 2025.
  • Median Other Non Operating Income over the past 5 years was $1.7 million (2021), compared with a mean of -$4.1 million.
  • Biggest five-year swings in Other Non Operating Income: soared 7474.24% in 2021 and later crashed 1022.3% in 2024.
  • Legend Biotech's Other Non Operating Income stood at $4.9 million in 2021, then soared by 88.19% to $9.2 million in 2022, then surged by 318.52% to $38.3 million in 2023, then soared by 190.62% to $111.4 million in 2024, then tumbled by 102.15% to -$2.4 million in 2025.
  • The last three reported values for Other Non Operating Income were -$2.4 million (Q4 2025), $354000.0 (Q3 2025), and -$108.1 million (Q2 2025) per Business Quant data.